Literature DB >> 12015428

Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus.

Anthony N van den Pol1, Prabhat K Ghosh, Rong-Jian Liu, Ying Li, George K Aghajanian, Xiao-Bing Gao.   

Abstract

The noradrenergic neurons of the locus coeruleus (LC) play an important role in modulating arousal and selective attention. A similar function has been attributed to the hypocretin neurons of the hypothalamus which maintain a strong synaptic projection to the LC. As the LC can be difficult to detect in the embryonic and neonatal mouse brain, we used a new transgenic mouse with strong GFP expression in the LC under the regulation of a mouse prion promoter. GFP colocalized with immunoreactive tyrosine hydroxylase in sections and dispersed cultures of the LC, allowing visualization and whole cell or single-unit recording from the LC in early stages of cellular development. GFP expression in the LC had no apparent effect on cellular physiology, including resting membrane potential, input resistance, spike threshold, depolarization-induced spike frequency increase, current-voltage relations, or hypocretin responses. In slices of the mature mouse and rat LC, hypocretin-1 and -2 increased spike frequency, with hypocretin-1 being an order of magnitude more potent. In the postnatal day (P) 0-2 developing mouse slice during a developmental period when spikes could be elicited in some cells, other developing LC neurons showed rhythmic, subthreshold oscillations (approximately 1 Hz) in membrane potential (2.9-7.4 mV amplitude); others were arrhythmic. Hypocretin-1 depolarized the membrane potential, resulting in the appearance of spikes in developing LC cells that showed no spikes under control conditions. In the presence of TTX and glutamate receptor antagonists, hypocretin-1-mediated inward currents were blocked by substitution of choline-Cl for NaCl, suggesting an excitatory mechanism based on an inward cation current. Hypocretin-1 initiated strong regular membrane voltage oscillations in arrhythmic immature neurons. Hypocretin increased the temporal synchrony of action potentials studied with dual-cell recording in P1-P5 mouse LC slices, consistent with the view that synchrony of LC output, associated with improved cognitive performance, may be increased by hypocretin. Together these data suggest that the hypothalamus, via hypocretin projections, may therefore be in a position to enhance arousal and modulate plasticity in higher brain centres through the developing LC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12015428      PMCID: PMC2290314          DOI: 10.1113/jphysiol.2002.017426

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  54 in total

Review 1.  Molecular control of locus coeruleus neurotransmission.

Authors:  E J Nestler; M Alreja; G K Aghajanian
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

2.  Lateral hypothalamus: early developmental expression and response to hypocretin (orexin).

Authors:  A N Van Den Pol; P R Patrylo; P K Ghosh; X B Gao
Journal:  J Comp Neurol       Date:  2001-05-07       Impact factor: 3.215

3.  Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

Authors:  P Bourgin; S Huitrón-Résendiz; A D Spier; V Fabre; B Morte; J R Criado; J G Sutcliffe; S J Henriksen; L de Lecea
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

4.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.

Authors:  T L Horvath; C Peyron; S Diano; A Ivanov; G Aston-Jones; T S Kilduff; A N van Den Pol
Journal:  J Comp Neurol       Date:  1999-12-13       Impact factor: 3.215

5.  Modification of postnatal development of neocortex in rat brain with experimental deprivation of locus coeruleus.

Authors:  T Maeda; M Toyama; N Shimizu
Journal:  Brain Res       Date:  1974-04-26       Impact factor: 3.252

6.  Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation.

Authors:  J M Lauder; F E Bloom
Journal:  J Comp Neurol       Date:  1974-06-15       Impact factor: 3.215

Review 7.  Narcolepsy: a neurodegenerative disease of the hypocretin system?

Authors:  A N van den Pol
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

8.  Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat.

Authors:  Timothy J Grudt; Anthony N van den Pol; Edward R Perl
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

9.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  54 in total

1.  Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation.

Authors:  Scott F Davis; Kevin W Williams; Weiye Xu; Nicholas R Glatzer; Bret N Smith
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

Review 2.  Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.

Authors:  Ming-Hu Han; Allyson K Friedman
Journal:  Neuropharmacology       Date:  2011-09-17       Impact factor: 5.250

3.  Inhibitory neurones of the spinal substantia gelatinosa mediate interaction of signals from primary afferents.

Authors:  Jihong Zheng; Yan Lu; Edward R Perl
Journal:  J Physiol       Date:  2010-04-19       Impact factor: 5.182

4.  GABA excitation in mouse hilar neuropeptide Y neurons.

Authors:  Li-Ying Fu; Anthony N van den Pol
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

5.  Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system.

Authors:  Marsida Kallupi; Nazzareno Cannella; Daina Economidou; Massimo Ubaldi; Barbara Ruggeri; Friedbert Weiss; Maurizio Massi; Juan Marugan; Markus Heilig; Patricia Bonnavion; Luis de Lecea; Roberto Ciccocioppo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

6.  Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity.

Authors:  Heinrich S Gompf; Gary Aston-Jones
Journal:  Brain Res       Date:  2008-06-03       Impact factor: 3.252

7.  Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor.

Authors:  Kay Jüngling; Xiaobin Liu; Jörg Lesting; Philippe Coulon; L Sosulina; Rainer K Reinscheid; Hans-Christian Pape
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

8.  Reversed synaptic effects of hypocretin and NPY mediated by excitatory GABA-dependent synaptic activity in developing MCH neurons.

Authors:  Ying Li; Youfen Xu; Anthony N van den Pol
Journal:  J Neurophysiol       Date:  2012-12-19       Impact factor: 2.714

9.  Connexin45-containing neuronal gap junctions in rodent retina also contain connexin36 in both apposing hemiplaques, forming bihomotypic gap junctions, with scaffolding contributed by zonula occludens-1.

Authors:  Xinbo Li; Naomi Kamasawa; Cristina Ciolofan; Carl O Olson; Shijun Lu; Kimberly G V Davidson; Thomas Yasumura; Ryuichi Shigemoto; John E Rash; James I Nagy
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

10.  GAD67-GFP knock-in mice have normal sleep-wake patterns and sleep homeostasis.

Authors:  Lichao Chen; James T McKenna; Michael Z Leonard; Yuchio Yanagawa; Robert W McCarley; Ritchie E Brown
Journal:  Neuroreport       Date:  2010-02-17       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.